Aspirin therapy: Optimized platelet inhibition with different loading and maintenance doses
- 30 September 1995
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 130 (3) , 465-472
- https://doi.org/10.1016/0002-8703(95)90353-4
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery diseaseThe Lancet, 1990
- Human gastric mucosal bleeding induced by low dose aspirin, but not warfarin.BMJ, 1989
- Clinical pharmacology of platelet cyclooxygenase inhibition.Circulation, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.Journal of Clinical Investigation, 1983
- Selective Cumulative Inhibition of Platelet Thromboxane Production by Low-dose Aspirin in Healthy SubjectsJournal of Clinical Investigation, 1982
- ASPIRIN AND PLATELETSThe Lancet, 1980
- Effects of prostacyclin (PGX) on cyclic AMP concentrations in human plateletsProstaglandins, 1977
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Aggregation of Blood Platelets by Adenosine Diphosphate and its ReversalNature, 1962